Under construction – not a live service
Sign in

Dermatomyositis and polymyositis (myositis) trials, also abroad

124 open Dermatomyositis and polymyositis (myositis) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States45
China38
France31
Germany24
Spain17
Italy14
Poland13
Netherlands11
Bulgaria10
Australia9
Czechia9
United Kingdom9
Hungary9
Japan9
Taiwan8
Austria7
Brazil7
Sweden7
Argentina6
Belgium6
South Korea6
Portugal6
Romania6
Israel5
Mexico5
Türkiye5
Denmark4
Norway4
Croatia3
India3
Serbia3
Greece2
Hong Kong2
Slovakia2
Thailand2
Chile1
Cyprus1
Georgia1
Guadeloupe1
Ireland1
Lithuania1
New Zealand1
Panama1
Peru1
Pakistan1
Puerto Rico1
Singapore1
Vietnam1

The same trial often runs in several countries

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) has 2 sites in Canada and runs in 29 countries. If a site near you is full, another one may still take people.

See A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) in all 29 countries